St. Christopher's Hospital for Children is a pediatric acute care hospital located in Philadelphia, Pennsylvania. The hospital has 188 beds and is affiliated with both the Drexel University College of Medicine and the Temple University School of Medicine.

There are 189 beds in St. Christopher's Hospital for Children.

During the past decade, St. Christopher's Hospital for Children conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 67 clinical trials were completed, i.e. on average, 117.5% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 25 clinical trials were completed. i.e. 108.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Christopher's Hospital for Children" #1 sponsor was "Children's Oncology Group" with 113 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 30 trials sponsored, "National Cancer Institute (NCI)" with 28 trials sponsored, "Gilead Sciences" with 8 trials sponsored and "Drexel University" with 8 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Christopher's Hospital for Children" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Cystic Fibrosis Foundation" with 7 trials as a collaborator and "Children's Oncology Group" with 6 trials as a collaborator. Other collaborators include 111 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "St. Christopher's Hospital for Children" are "HIV Infections" (35 trials), "Leukemia" (17 trials), "Cystic Fibrosis" (16 trials), "Neuroblastoma" (10 trials) and "Sarcoma" (10 trials). Many other conditions were trialed in "St. Christopher's Hospital for Children" in a lesser frequency.

Most popular intervention types in "St. Christopher's Hospital for Children" are "Drug" (180 trials), "Other" (69 trials), "Biological" (65 trials), "Procedure" (60 trials) and "Radiation" (50 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Cyclophosphamide" (31 trials), "cyclophosphamide" (28 trials), "Vincristine Sulfate" (27 trials) and "etoposide" (27 trials). Other intervention names were less common.

The vast majority of trials in "St. Christopher's Hospital for Children" are 244 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St. Christopher's Hospital for Children". undefined are not yet recruiting, 36 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 153 completed trials in St. Christopher's Hospital for Children, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in St. Christopher's Hospital for Children, 21 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 19 trials that are defined as “Not Applicable".